186 related articles for article (PubMed ID: 38118002)
21. Demethylation-activated light-up dual-color RNA aptamersensor for label-free detection of multiple demethylases in lung tissues.
Liu XW; Zhao NN; Yuan HM; Li DL; Liu M; Zhang CY
Biosens Bioelectron; 2024 Mar; 247():115966. PubMed ID: 38147719
[TBL] [Abstract][Full Text] [Related]
22. The Role of Key Amino Acids of the Human Fe(II)/2OG-Dependent Dioxygenase ALKBH3 in Structural Dynamics and Repair Activity toward Methylated DNA.
Kanazhevskaya LY; Gorbunov AA; Lukina MV; Smyshliaev DA; Zhdanova PV; Lomzov AA; Koval VV
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256217
[TBL] [Abstract][Full Text] [Related]
23. Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs.
Chen Z; Qi M; Shen B; Luo G; Wu Y; Li J; Lu Z; Zheng Z; Dai Q; Wang H
Nucleic Acids Res; 2019 Mar; 47(5):2533-2545. PubMed ID: 30541109
[TBL] [Abstract][Full Text] [Related]
24. Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis.
Cohen C; Corpet A; Roubille S; Maroui MA; Poccardi N; Rousseau A; Kleijwegt C; Binda O; Texier P; Sawtell N; Labetoulle M; Lomonte P
PLoS Pathog; 2018 Sep; 14(9):e1007313. PubMed ID: 30235352
[TBL] [Abstract][Full Text] [Related]
25. ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer.
Tasaki M; Shimada K; Kimura H; Tsujikawa K; Konishi N
Br J Cancer; 2011 Feb; 104(4):700-6. PubMed ID: 21285982
[TBL] [Abstract][Full Text] [Related]
26. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J
J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875
[TBL] [Abstract][Full Text] [Related]
27. PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic Agent.
Song C; Wang L; Wu X; Wang K; Xie D; Xiao Q; Li S; Jiang K; Liao L; Yates JR; Lee JD; Yang Q
Cancer Res; 2018 May; 78(10):2475-2489. PubMed ID: 29735542
[TBL] [Abstract][Full Text] [Related]
28. PML Nuclear bodies: the cancer connection and beyond.
Abou-Ghali M; Lallemand-Breitenbach V
Nucleus; 2024 Dec; 15(1):2321265. PubMed ID: 38411156
[TBL] [Abstract][Full Text] [Related]
29. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
[TBL] [Abstract][Full Text] [Related]
30. ALKBH3-dependent m
Kuang W; Jin H; Yang F; Chen X; Liu J; Li T; Chang Y; Liu M; Xu Z; Huo C; Yan X; Yang Y; Liu W; Shu Q; Xie S; Zhou T
Cell Discov; 2022 Mar; 8(1):25. PubMed ID: 35277482
[TBL] [Abstract][Full Text] [Related]
31. Demethylation of m1A assisted degradation of the signal probe for rapid electrochemical detection of ALKBH3 activity with practical applications.
Cheng W; Ma J; Tao Q; Adeel K; Xiang L; Liu D; Zhang Z; Li J
Talanta; 2022 Apr; 240():123151. PubMed ID: 34942472
[TBL] [Abstract][Full Text] [Related]
32. m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer.
Zhao Y; Zhao Q; Kaboli PJ; Shen J; Li M; Wu X; Yin J; Zhang H; Wu Y; Lin L; Zhang L; Wan L; Wen Q; Li X; Cho CH; Yi T; Li J; Xiao Z
Transl Oncol; 2019 Oct; 12(10):1323-1333. PubMed ID: 31352195
[TBL] [Abstract][Full Text] [Related]
33. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
34. PML nuclear body-residing proteins sequentially associate with HPV genome after infectious nuclear delivery.
Guion L; Bienkowska-Haba M; DiGiuseppe S; Florin L; Sapp M
PLoS Pathog; 2019 Feb; 15(2):e1007590. PubMed ID: 30802273
[TBL] [Abstract][Full Text] [Related]
35. ALKBH3 partner ASCC3 mediates P-body formation and selective clearance of MMS-induced 1-methyladenosine and 3-methylcytosine from mRNA.
Wollen KL; Hagen L; Vågbø CB; Rabe R; Iveland TS; Aas PA; Sharma A; Sporsheim B; Erlandsen HO; Palibrk V; Bjørås M; Fonseca DM; Mosammaparast N; Slupphaug G
J Transl Med; 2021 Jul; 19(1):287. PubMed ID: 34217309
[TBL] [Abstract][Full Text] [Related]
36. anti-tumor effect of AlkB homolog 3 knockdown in hormone- independent prostate cancer cells.
Koike K; Ueda Y; Hase H; Kitae K; Fusamae Y; Masai S; Inagaki T; Saigo Y; Hirasawa S; Nakajima K; Ohshio I; Makino Y; Konishi N; Yamamoto H; Tsujikawa K
Curr Cancer Drug Targets; 2012 Sep; 12(7):847-56. PubMed ID: 22515525
[TBL] [Abstract][Full Text] [Related]
37. Indenone derivatives as inhibitor of human DNA dealkylation repair enzyme AlkBH3.
Nigam R; Babu KR; Ghosh T; Kumari B; Akula D; Rath SN; Das P; Anindya R; Khan FA
Bioorg Med Chem; 2018 Aug; 26(14):4100-4112. PubMed ID: 30041948
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional organization of promyelocytic leukemia nuclear bodies.
Lang M; Jegou T; Chung I; Richter K; Münch S; Udvarhelyi A; Cremer C; Hemmerich P; Engelhardt J; Hell SW; Rippe K
J Cell Sci; 2010 Feb; 123(Pt 3):392-400. PubMed ID: 20130140
[TBL] [Abstract][Full Text] [Related]
39. The SP100 component of ND10 enhances accumulation of PML and suppresses replication and the assembly of HSV replication compartments.
Xu P; Roizman B
Proc Natl Acad Sci U S A; 2017 May; 114(19):E3823-E3829. PubMed ID: 28439026
[TBL] [Abstract][Full Text] [Related]
40. TP53 gene status is a critical determinant of phenotypes induced by ALKBH3 knockdown in non-small cell lung cancers.
Kogaki T; Ohshio I; Kawaguchi M; Kimoto M; Kitae K; Hase H; Ueda Y; Jingushi K; Tsujikawa K
Biochem Biophys Res Commun; 2017 Jun; 488(2):285-290. PubMed ID: 28479246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
